Testing Genetic Markers for Parkinson's Disease Risk
Author Information
Author(s): Yonghong Li, Charles Rowland, Georgia Xiromerisiou, Robert J. Lagier, Steven J. Schrodi, Efthimios Dradiotis, David Ross, Nam Bui, Joseph Catanese, Konstantinos Aggelakis, Andrew Grupe, Georgios Hadjigeorgiou
Primary Institution: Celera, Alameda, California, United States of America
Hypothesis
Can a panel of genetic markers in the axon guidance pathway predict the risk of Parkinson's disease?
Conclusion
The study found no strong evidence supporting the axon guidance pathway's role in predicting Parkinson's disease risk.
Supporting Evidence
- Only one marker was significantly associated with PD risk in one sample set.
- Multi-marker analysis showed a mild association in one sample set but not in the other.
- Simulated models produced highly significant P-values, indicating potential overfitting.
Takeaway
The researchers looked at genes to see if they could predict who might get Parkinson's disease, but they didn't find strong proof that these genes are helpful.
Methodology
The study genotyped 23 SNPs in two independent case-control sample sets and analyzed their association with Parkinson's disease risk.
Potential Biases
Potential overfitting due to the selection of SNPs and models based on previous findings.
Limitations
The study could not replicate the findings of previous studies and faced challenges with the SNP selection process.
Participant Demographics
The study included white participants from two sample sets, with cases and controls matched by age and gender.
Statistical Information
P-Value
0.034
Confidence Interval
95% CI: 0% to 14%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website